Patient Guide: A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 114 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05785624
Status: 🟢 Enrolling Now
Condition: Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement
Phase: PHASE2

Where You Can Participate

This study is available at 114 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Phoenix, Arizona
  • • Tucson, Arizona
  • • And 111 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - Join Clinical Trial NCTNCT05785624

How to Join This Clinical Trial - NCTNCT05785624

Learn how to participate in this PHASE2 trial studying an investigational therapy for Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05785624 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 114 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85006-2506 - United States

Status: RECRUITING

Clinical Research Site

Tucson, Arizona 85723-0001 - United States

Status: RECRUITING

Clinical Research Site

Fresno, California 93701-2302 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90033-1036 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90095-8344 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94143-2204 - United States

Status: RECRUITING

Clinical Research Site

Torrance, California 90502 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Ocala, Florida 34470 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32803 - United States

Status: WITHDRAWN

And 104 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships